Policy Forum Chair Laura Sampietro-Colom (Spain), 2016-19
Laura Sampietro-Colom is Head of the Health Technology Assessment (HTA) Unit in the Research and Innovation Directorate at the Hospital Clinic of Barcelona, a high-tech hospital and a reference for health care, research, innovation and medical training in Spain. She is also the Chair-Elect of the HTAi Policy Forum and Chair of the first Latin-American HTAi Policy Forum. Prior to this, she was the General Director of Information Systems, Projects and Evaluation of the Catalan Health Institute, the leading provider of public health services in the Region of Catalonia and the Director of the Strategic Planning Unit of Health Services within the Planning and Evaluation Directorate of the Ministry of Health of Catalonia, Spain.
Sampietro-Colom has over 20 years of experience in evaluative research, specifically in HTA and was one of the founders of the Catalan Agency for Health Technology Assessment (nowadays AQuAS). She was the Founding member of the International Society for Health Technology Assessment (HTAi), serving on the Board of Directors since its foundation and being its President for two years. Responsible for the development of one of the research lines of the first international project conducted by the International Network of Agencies for Health Technology Assessment (INAHTA), she has also worked in several EU HTA projects; including the coordination of AdHopHTA, the first EU funded project on hospital-based HTA. She has been temporary adviser of the United Nations Agencies WHO and PAHO. She advises on HTA strategies to public and private organisations worldwide. She is also mentoring the development of innovations under the umbrella of a capital risk/foundation program (“Caixaimpulse”).
Sampietro-Colom is a trained Medical Doctor; Board Certified Specialist in Preventive Medicine and Public Health (University of Barcelona) and holds a PhD in Medicine and Surgery by the Autonomous University of Barcelona, and a Master of Science in Public Health by the Rolling School of Public Health (Emory University, Atlanta, USA) as well as post graduate courses in Health Economics, Management of Health Care Institutions and Management of Innovation & Science. Throughout, her work has focused on the development, identification, management and transfer of information to advise on the designing of strategies and policies in the areas of assessment, planning and access of medical devices, drugs, surgical procedures and other health care technologies as well as health care programs.
Editor in Chief, International of Technology Assessment in Health Care, Wendy Babidge (Australia)
Wendy Babidge is Director of the Research, Audit and Academic Surgery Division of the Royal Australasian College of Surgeons. This role was established in 2005 after the expansion of research and audit activities in the Division, following the establishment of the Australian Safety and Efficacy Register of New Interventional Procedures-Surgical (ASERNIP- S) in 1998.
Wendy has an Honours Degree in Biotechnology, a PhD from the University of Adelaide and a Graduate Diploma in Business. She is a Graduate of the Australian Institute of Company Directors, a Fellow of the Australian Institute of Management and an Associate Professor of the University of Adelaide.
Wendy is the past Chair of the International Network of Agencies for Health Technology Assessment (INAHTA) Board and, following several years as a Deputy Editor for the International Journal of Technology Assessment in Health Care was appointed as the Editor-in-Chief in 2016.
INAHTA Board Chair, Sophie Werkö (Sweden)
Sophie Werkö has an MSc in Business Administration, IBA, and a PhD from the University of Stockholm. She has a longstanding engagement with HTA and held the role as Project Director at The Swedish Council on Health Technology Assessment (SBU) including project management, systematic literature reviews and health technology assessment reports. In 2012 she was appointed Manager of International Relations at SBU, responsible for coordinating SBU’s international work.
Since 2010, Werkö has attended the annual meetings of INAHTA and is together with David Hailey chairing the working group on Impact. She is a member of the steering committee of the Health Technology Assessment International (HTAi) Interest Group on Patient and Citizens Involvement since 2007. She is also the chair of the HTAi subgroup on Patient Issues: Methods and Impact Working Group which she set up in 2011 together with Sophie Staniszewska and Javier Gracia San Roman and has managed the group since then. She has participated in The European network for Health Technology Assessment’s (EUnetHTA’s) Work Package 4 on the HTA Core Model (focusing on the core methodology of HTAs) since 2009 and she also had a seat in the EUnetHTA Executive Committee Joint Action 1. She has presented at many national and international conferences, with panel presentations at HTAi in Rio de Janeiro, Brazil (2011). She has several peer-reviewed publications in international and national journals and acts as a reviewer of manuscripts for several international journals.